인도의 방사선 치료 기기 시장 규모는 2024년도 4억 1,222만 달러에서 2032년도에 7억 827만 달러에 달할 것으로 예측되며, 2025년도-2032년도에 CAGR로 7.00%의 성장이 전망됩니다. 시장은 암 부담 증대, 현지 생산, 기술의 진보, 민관 파트너십에 의해 성장하고 있습니다.
시장은 신규 암환자의 증가, 의료 지출의 증가, 정부의 암 치료 강화 노력으로 시장이 확대되고 있습니다. 경기 호황과 중산층 인구의 급격한 증가로 인해 첨단 의료 기술 도입에 막대한 투자가 이루어지고 있습니다. 또한 강력한 현지 역량으로 의료기기 생산의 자급자족을 달성하여 수입 의존도를 낮추려는 동기가 있습니다. 강력한 민관 파트너십을 통해 첨단 치료 센터의 설립이 용이해졌습니다. 또한 검진 및 암 조기 발견에 대한 인식이 높아지면서 방사선 치료 서비스에 대한 수요도 증가하고 있습니다. 세계 의료 허브로서의 입지를 구축하고자 하는 인도의 열망은 양질의 암 치료를 제공하고 국제 시장에서 경쟁력을 갖추기 위해 필수적인 첨단 방사선 치료 기기를 배치할 필요성을 불러일으키고 있습니다.
또한 암 전문센터 및 방사선 치료 시설과 같은 의료 센터의 확대로 방사선 치료 기기의 가용성과 접근성이 향상될 것입니다. 예를 들어 2024년 4월 뉴델리에 위치한 레이디 하딩지 의과대학(Lady Hardinge Medical College)은 처음으로 암 환자를 위한 방사선 치료를 시작했습니다. 이 치료는 일부 암 및 기타 질환을 앓고 있는 환자들에게 제공될 예정입니다. 더 많은 시설이 설립되면 방사선 치료 서비스에 대한 접근성이 향상되고 그 결과 환자의 추가 치료에 대한 방사선 치료 기기에 대한 수요가 증가할 것입니다.
인도의 방사선 치료 기기 시장에 대해 조사분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업의 상황 등을 제공하고 있습니다.
India radiotherapy devices market is projected to grow at a CAGR of 7.00% from FY2025 to FY2032, increasing from USD 412.22 million in FY2024 to USD 708.27 million by FY2032. The market for radiotherapy devices in India is growing due to an increase in the cancer burden, indigenous manufacturing, technological advancements, and public-private partnerships.
The Indian radiotherapy devices market is expanding as new cancer cases are growing, healthcare expenditure is rising, and the government is taking initiatives to enhance cancer care. The booming economy and rapidly growing middle-class population in the nation have resulted in huge investments in adopting advanced healthcare technologies. Moreover, the motivation for the achievement of self-sufficiency in the production of medical equipment with strong indigenous capabilities is to reduce the dependence on imports. Strong public-private partnerships are making it easy to establish advanced treatment centers. Also, the increasing awareness of screening and early cancer detection further results in rising demand for radiotherapy services. The country's aspirations to position itself as a global healthcare hub create the need to equip the country with advanced radiotherapy equipment, which would prove indispensable in supplying quality cancer care and placing the country competitively in the international market.
Furthermore, the expansion of healthcare centers, such as specialized centers of cancer and radiation therapy facilities, enhances the availability and accessibility of radiotherapy equipment. For instance, in April 2024, Lady Hardinge Medical College, located in New Delhi, inaugurated and treated its first cancer patient with brachytherapy equipment. This treatment is provided for patients suffering from some kinds of cancers and other diseases. With more facilities being set up, this will increase accessibility to radiotherapy services, hence increasing the demand for radiotherapy devices in further treatment of patients.
Increasing Cancer Burden Influencing India Radiotherapy Devices Market Growth
The rising burden of cancer cases in India is resulting in a higher demand for radiotherapy devices, which, in turn, leads to the expansion of the radiotherapy devices market. The alarming increase in cancer cases in India, which gets worsened by significantly delayed diagnoses resulting in higher mortality rates along with lower recoveries, necessitates raising public awareness and educational awareness among professionals to address this significant issue. Predictive and precision medicine, and integrated AI diagnostics, provide further hope to tackle this issue. The demand for radiotherapy devices is expected to significantly increase as diagnostic methods become more common and affordable. Increasingly systematic screening programs focusing on prevalent cancers, as well as on high-risk individuals, are essential. Risk identification and improvement of data sharing constitute part of the government's digital health initiatives. Collaboration between the public and private sectors is of utmost importance in adequately dealing with the growing burden of cancer. Such interaction will promote demand for better-advanced radiotherapy technologies that improve patient care and outcomes. Public-Private Partnerships (PPPs) have significantly increased access to cancer care in India. For example, Varian Medical Systems, Inc. has partnered with the Central and State Governments to establish radiation therapy centers in public hospitals. The government provides the infrastructure, while private operators supply the equipment and services at agreed-upon prices for the benefit of patients.
Increasing Government Initiatives to Drive the Radiotherapy Devices Market Growth
The government has initiated various schemes and policies to encourage growth in the medical devices market, particularly radiotherapy equipment. The Make in India initiative supports the domestic manufacturing of medical devices, including those used in cancer treatment, to reduce import dependency. Moreover, in the Production Linked Incentive Scheme (PLI) scheme, incentives are proposed for specific cancer care technologies, including advanced radiotherapy technologies.
Such developments allow growth and innovation for the medical industry in India, which, in turn, attracts investments that help research institutions develop technology to increase the adoption of advanced medical devices in health facilities. In this case, with growing awareness about treatments for cancer treatment, more patients will look at the need for advanced therapies, increasing device demand and promoting the Indian radiotherapy devices market progression. For instance, in June 2024, Apollo Cancer Centres partnered with Accuray Medical Equipment India Pvt. Ltd., to introduce India's first Robotic Stereotactic Radiotherapy Program. It will provide advanced training for radiation oncologists, physicists, and technicians in Chennai and Bangalore locations. This program will feature hands-on training and in-depth discussions to enhance local medical education, providing improved cancer care using the Cyberknife system.
Developments in Technology to Propel India Radiotherapy Devices Market Growth
With the increase in cancer cases, there is an emerging demand for advanced technologies in treatment, especially among late-stage cancers that are challenging to treat. The rise in cancer cases in India highlights the market for an advanced and affordable healthcare system covering cancer care so that anyone can easily approach cancer care. Innovations in radiotherapy from key players in the healthcare sector are involved in improving comfort for cancer patients. Many hospitals and medical facilities have embraced these innovations. Advanced treatment techniques used include proton therapy, precision radiation therapies such as intensity-modulated radiation therapy, and image-guided radiation therapy. For instance, in August 2024, Sahyadri Hospitals Private Limited installed the TomoTherapy Radixact X9 system with VitalHold technology. This radiotherapy solution has unfolded new dimensions in treating cancer by providing precision, significantly when tumors are affected by patient movement. It is the first installation in Asia with the system and features Auto Beam Hold, which will cease radiation if the patient moves beyond safe limits. Advanced imaging capabilities significantly improve the detection and accuracy of treatment in tumors, hence elevating patient care.
Hospitals to Hold Substantial Market Share
Hospitals in India account for a relatively more significant share of the radiotherapy devices market due to the increasing patient requirements for cancer treatment, technological advancements, and government initiatives towards healthcare infrastructure development. Their capability to provide comprehensive care invests in modern equipment that enhances the quality of service delivered. This trend accelerates market growth, attracts further investments in innovations, and brings about healthy competition among the manufacturers, which results in better accessibility and affordability of radiotherapy services amongst patients located in various parts of the country. Therefore, hospitals are increasingly installing such advanced radiotherapy devices in their facility to improve patient outcomes. For instance, in April 2024, the Swami Rama Himalayan University (SRHU) Cancer Research Institute (Himalayan Hospital) installed the Halcyon B Linear Accelerator for radiotherapy at the Himalayan Hospital. With cancer cases on a leap and bound in India, this high-end machine will enhance the present treatment portfolio of the patients. Being the first private teaching hospital in Uttarakhand wielding this technology, Himalayan Hospital would ensure the pain of the side effects among its affected patients is not so grueling during treatment and, hence, bring a highly positive change.
Future Market Scenario (FY2025 -FY2032F)
Technologically advanced elements, such as precision radiation therapy, integration of AI for treatment planning, and new technologies like proton therapy, will drive the Indian market for radiotherapy devices. Major companies are stressing cost-effective solutions and are enhancing patient care through personalized treatment approaches. In September 2024, Accuray Medical Equipment India Pvt. Ltd (Accuray) unveiled its CE-marked Accuray Helix system in India. The CT-guided helical radiotherapy system will provide high performance and efficiency, reaching into emerging markets where advanced cancer care, including radiotherapy is often limited to urban areas with fewer facilities such as a linear accelerator.
Key Players Landscape and Outlook
Major players in India radiotherapy devices market are building their presence through partnerships with government hospitals, increasing the distribution outreach, and investing in local manufacturing. It includes improving access to best-in-class cancer treatment and resultant gains to strengthen their competitive position in the market.
In November 2023, Elekta AB (Elekta) received an order worth USD 40 million from Krishna Institute of Medical Sciences (KIMS) in Hyderabad. The order includes cutting-edge equipment like the Elekta Unity MR-Linacs and Leksell Gamma Knife systems, which will enable KIMS to deliver more personalized cancer treatments and enhance the care of their patients while minimizing side effects.
In July 2023, Elekta AB (Elekta) collaborated with GE HealthCare Technologies Inc., intending to scale up accessibility to precise radiation therapy in India. Through this agreement, these companies will ensure that complete systems for imaging and treatment are delivered to hospitals, providing radiation therapy to cancer patients and, hence, improving the care of patients.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.